A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 37
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CDO1
Long Form : cysteine dioxygenase 1
No. Year Title Co-occurring Abbreviation
2022 A BIRC5High COD1Low Cancer Tissue Phenotype Indicates Poorer Prognosis of Metastatic Breast Cancer Patients. BIRC5, OS, RFS, TNBC
2022 Hypermethylated CDO1 and ZNF454 in Cytological Specimens as Screening Biomarkers for Endometrial Cancer. AH, AUC, EC, qMSP, Se, Sp, ZNF454
2022 Predictive Significance of Promoter DNA Methylation of Cysteine Dioxygenase Type 1 (CDO1) in Metachronous Gastric Cancer. EGC, ESD, MGC, TAM
2021 Endogenous Taurine Downregulation Is Required for Renal Injury in Salt-Sensitive Hypertensive Rats via CBS/H2S Inhibition. CBS, CSAD, RAAS, SBP, SOD1, SOD2
2021 Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer. CEA, CY, GC, pT
2020 Analysis of the methylation of CpG islands in the CDO1, TAC1 and CHFR genes in pancreatic ductal cancer. CHFR, TAC1
2020 Metabolism of Sulfur-Containing Amino Acids: How the Body Copes with Excess Methionine, Cysteine, and Sulfide. CBS, Cys, GNMT, Hcy, MAT, Met, SAM
2020 Molecular analysis of the human placental cysteine dioxygenase type 1 gene. ---
2020 Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN). HGD, IC, IPMN, qMSP
10  2020 Promoter hypermethylation of cysteine dioxygenase type 1 in patients with non-small cell lung cancer. cMSP, MOB-qMSP, NSCLC
11  2019 Cancer-specific promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene as an important prognostic biomarker of gastric cancer. p-stage
12  2019 Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer. CRC, SBC
13  2019 Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer. CSA, NSCLC
14  2019 Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer. AUC, EUS-FNA, MV, PDAC
15  2019 Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer. BC, HOPX
16  2018 Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer. ACS, CRC, NAM
17  2018 Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy. CRC, MMP, PCR
18  2018 HNF4alpha Regulates CSAD to Couple Hepatic Taurine Production to Bile Acid Synthesis in Mice. ASBT, CSAD, FXR, HNF4alpha, SHP
19  2018 Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma. AC, BTC, EHCC, OS
20  2017 Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. GC, GPX4, ROS
21  2017 Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease. GBC, qMSP
22  2017 Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma. HCC
23  2017 The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma. BEA
24  2016 CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients. BCR, PCa
25  2016 Cysteine Dioxygenase Type 1 Inhibits Osteogenesis by Regulating Wnt Signaling in Primary Mouse Bone Marrow Stromal Cells. ALP, BMSCs, MSCs
26  2016 Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. BC, qMSP
27  2015 Cysteine dioxygenase type 1 promotes adipogenesis via interaction with peroxisome proliferator-activated receptor gamma. mBMSCs
28  2015 Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma. ESCC
29  2015 Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome. ccRCC, CI, NLCS
30  2014 Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study. CRC
31  2014 Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas. DDLSs, hMSCs, IHC, WDLSs
32  2014 Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. CHB, HBV, HCC, LC, MSP
33  2013 Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. CSA
34  2013 Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. ROS
35  2012 Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. CRC
36  2011 The synthesis and role of taurine in the Japanese eel testis. CSD, DHP
37  2010 CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients. LNP